Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.09% | 4.78% | 5.65% | 6.91% | 2.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.09% | 4.78% | 5.65% | 6.91% | 2.70% |
| Cost of Revenue | 3.89% | 7.22% | 8.32% | 9.91% | 2.07% |
| Gross Profit | 4.34% | 1.63% | 2.25% | 3.42% | 3.52% |
| SG&A Expenses | 1.47% | 1.50% | 2.77% | 1.14% | -0.27% |
| Depreciation & Amortization | 4.12% | 10.21% | 7.62% | -7.17% | -3.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.99% | 5.07% | 6.21% | 6.32% | 1.14% |
| Operating Income | 15.00% | 1.40% | -0.41% | 12.00% | 21.32% |
| Income Before Tax | 234.98% | -165.85% | -23.61% | 179.11% | -21.56% |
| Income Tax Expenses | 132.60% | -38.19% | 1.15% | -8.73% | 28.91% |
| Earnings from Continuing Operations | 323.61% | -234.17% | -35.53% | 140.47% | -41.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -317.01% | 1,601.32% | 15.41% | -232.04% | -157.57% |
| Net Income | 323.69% | -205.48% | -34.86% | 140.24% | -42.96% |
| EBIT | 15.00% | 1.40% | -0.41% | 12.00% | 21.32% |
| EBITDA | 14.53% | 2.83% | 1.09% | 11.08% | 19.74% |
| EPS Basic | 322.07% | -205.10% | -35.10% | 140.08% | -43.15% |
| Normalized Basic EPS | 22.66% | 32.49% | 6.09% | -4.86% | 31.83% |
| EPS Diluted | 318.18% | -206.83% | -35.44% | 139.77% | -42.86% |
| Normalized Diluted EPS | 22.23% | 33.63% | 5.50% | -5.84% | 30.94% |
| Average Basic Shares Outstanding | 0.38% | 0.36% | 0.37% | 0.39% | 0.34% |
| Average Diluted Shares Outstanding | 0.72% | -0.49% | 0.93% | 1.44% | 1.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |